Nationwide real-world implementation of AI for cancer detection in population-based mammography screening (PRAIM)

The PRAIM study (PRospective multicenter observational study of an integrated AI system with live Monitoring) assessed the impact of an AI-based decision support software on breast cancer screening outcomes. This Dryad data package contains the anonymized data from 461 818 screening cases across 12 screening sites in Germany. Variables include screening outcomes like cancer detection, use of AI software, radiologist assessments, cancer characteristics, and further metadata. The data can be used to reproduce the analyses on performance of AI-supported breast cancer screening versus standard of care published in Nature Medicine: Nationwide real-world implementation of AI for cancer detection in population-based mammography screening.